Scott Juda's most recent trade in INmune Bio Inc was a trade of 14,801 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on July 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| INmune Bio Inc | Scott Juda | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. | 02 Jul 2026 | 14,801 | 86,404 (0%) | 0% | 1.4 | 20,721 | Common Stock |
| INmune Bio Inc | Scott Juda | Director | 02 Jul 2026 | 14,801 | 14,802 | - | - | Common Stock Purchase Warrant | ||
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2025 | 150,000 | 150,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 108,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 32,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 19,025 | 19,025 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 15,975 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 15,975 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Nov 2025 | 12,500 | 0 | - | - | Stock Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 32,500 | 32,500 | - | - | Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Purchase of securities on an exchange or from another person at price $ 7.27 per share. | 25 Jun 2024 | 5,000 | 71,603 (0%) | 0% | 7.3 | 36,350 | Common Stock |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 12,500 | 12,500 | - | - | Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Purchase of securities on an exchange or from another person at price $ 8.32 per share. | 19 Apr 2024 | 29,603 | 66,603 (0%) | 0% | 8.3 | 246,297 | Common Stock |
| INmune Bio Inc | Scott Juda | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Apr 2024 | 29,603 | 29,603 | - | - | Common Stock Warrants (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 35,000 | 35,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 35,000 | 35,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Scott Juda | Director | Purchase of securities on an exchange or from another person at price $ 13.55 per share. | 17 Nov 2021 | 2,500 | 30,000 (0%) | 0% | 13.6 | 33,875 | Common Stock |